Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 3 | +1.76 M | 100% | $0.76 | +$1.34 M |
Sells | 0 | ||||
Net | +3 | +1.76 M | 100% | +$1.34 M |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Stuart M. Grant | 10%+ Owner | $7.2 M | +$1.32 M | +22.4% | Jul 2, 2024 |
Fredric N. Eshelman | Director | $1.83 M | Nov 17, 2021 | ||
Tsontcho Ianchulev | Director | $1.54 M | Jun 12, 2024 | ||
Michael Rowe | Chief Executive Officer, Director | $836 K | +$11 K | +1.33% | Feb 12, 2024 |
Luke Clauson | VP Research & Development | $771 K | Jun 16, 2021 | ||
Ernest Mario | Director | $578 K | Nov 17, 2021 | ||
John P. Gandolfo | Chief Financial Officer | $421 K | Feb 12, 2024 | ||
Charles E. Mather IV | Director | $361 K | Jun 12, 2024 | ||
Ellen R. Strahlman | Director | $334 K | +$8.1 K | +2.48% | Jun 12, 2024 |
Bren Kern | Chief Operating Officer | $304 K | Feb 12, 2024 | ||
Rachel Jacobson | Director | $290 K | Jun 12, 2024 | ||
Michael Geltzeiler | Director | $284 K | Jun 12, 2024 | ||
Ram Palanki | Director | $283 K | Jun 12, 2024 | ||
Kenneth B. Lee Jr | Director | $273 K | Jun 16, 2022 | ||
Julia A. Haller | Director | $226 K | Jun 16, 2022 | ||
Stephen Keith Benjamin | Director | $220 K | Jun 16, 2022 | ||
Jennifer Clasby | VP, Regulatory and Clinical | $124 K | Jun 17, 2021 | ||
Curt H. LaBelle | Director | $115 K | Nov 17, 2021 | ||
Anthony Y. Sun | Director | $93.8 K | Nov 17, 2021 |
Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
---|